2AYR | Transcription | date | Sep 07, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | A Serm Designed For The Treatment Of Uterine Leiomyoma With Tissue Specificity For Uterus And Ovaries In Rats | ||||||||||||||
authors | C.W.Hummel, A.G.Geiser, H.U.Bryant, I.R.Cohen, R.D.Dally, K.C.Fon S.A.Frank, R.Hinklin, S.A.Jones, G.Lewis, D.J.Mccann, T.A.Shephe H.Tian, D.G.Rudman, O.B.Wallace, Y.Wang, J.A.Dodge | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Estrogen Receptor Chain: A Fragment: Ligand Binding Domain, Residues 304-551 Synonym: Er, Estradiol Receptor, Er-Alpha Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Esr1, Esr, Nr3a1 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 65 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | L4G BindingDB | enzyme |
| ||||||||||||
Primary reference | A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats., Hummel CW, Geiser AG, Bryant HU, Cohen IR, Dally RD, Fong KC, Frank SA, Hinklin R, Jones SA, Lewis G, McCann DJ, Rudmann DG, Shepherd TA, Tian H, Wallace OB, Wang M, Wang Y, Dodge JA, J Med Chem 2005 Nov 3;48(22):6772-5. PMID:16250633 |
Data retrieval |
View 2AYR in 3D |
Visual 3D analysis of 2AYR |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2AYR |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |